These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8925890)

  • 1. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.
    Pejler G
    FEBS Lett; 1996 Apr; 383(3):170-4. PubMed ID: 8925890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.
    Pejler G
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):897-903. PubMed ID: 9003378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.
    Pejler G; Söderström K; Karlström A
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):507-13. PubMed ID: 8172612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism by which heparin proteoglycan modulates mast cell chymase activity.
    Pejler G; Sadler JE
    Biochemistry; 1999 Sep; 38(37):12187-95. PubMed ID: 10508424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase.
    Sommerhoff CP; Ruoss SJ; Caughey GH
    J Immunol; 1992 May; 148(9):2859-66. PubMed ID: 1573274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A; Juliano MA; Juliano L; Pejler G
    Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the activity of secreted human lung mast cell tryptase by mast cell proteoglycans.
    Lindstedt KA; Kokkonen JO; Kovanen PT
    Biochim Biophys Acta; 1998 Nov; 1425(3):617-27. PubMed ID: 9838225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans.
    Matsumoto R; Sali A; Ghildyal N; Karplus M; Stevens RL
    J Biol Chem; 1995 Aug; 270(33):19524-31. PubMed ID: 7642636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin antagonists are potent inhibitors of mast cell tryptase.
    Hallgren J; Estrada S; Karlson U; Alving K; Pejler G
    Biochemistry; 2001 Jun; 40(24):7342-9. PubMed ID: 11401583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of rat mast cell protease 1 by vitronectin.
    Pejler G; Tomasini-Johansson BR
    FEBS Lett; 1994 Jun; 346(2-3):189-93. PubMed ID: 7516895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.
    Kokkonen JO; Kovanen PT
    Biochem J; 1987 Jan; 241(2):583-9. PubMed ID: 3593208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
    Sayama S; Iozzo RV; Lazarus GS; Schechter NM
    J Biol Chem; 1987 May; 262(14):6808-15. PubMed ID: 3553192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous effects of protamine on human mast cells and basophils.
    Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
    Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
    Paananen K; Kovanen PT
    J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.
    Frank BT; Rossall JC; Caughey GH; Fang KC
    J Immunol; 2001 Feb; 166(4):2783-92. PubMed ID: 11160345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.